Grimm et al developed a model and score for predicting the risk of acute renal failure following lung transplantation. This can help to identify a patient who may benefit from more aggressive management. The authors are from the Johns Hopkins Hospital in Baltimore.
Patient selection: lung transplantation
Outcome: new-onset renal failure
Parameters:
(1) race
(2) pulmonary diagnosis
(3) diabetes
(4) body mass index in kilograms per square meter
(5) baseline eGFR in mL per min per 1.73 square meter
(6) Karnofsky Performance Status (KPS) from 10 to 100
(7) ICU stay before transplant
(8) ECMO therapy before transplant
(9) days on waiting list
(10) number of lung transplanted
Parameter |
Finding |
Points |
race |
African American |
5 |
|
White or Hispanic |
0 |
|
other |
6 |
diagnosis |
sarcoidosis |
5 |
|
interstitial pulmonary fibrosis, cystic fibrosis, COPD, alpha-1 antitrypsin |
0 |
|
other |
5 |
diabetes |
no |
0 |
|
yes |
4 |
body mass index |
< 30 kg per square meter |
0 |
|
>= 30 kg per square meter |
7 |
baseline eGFR |
> 45 mL/min/1.73 sq m |
0 |
|
<= 45 |
7 |
KPS |
80 to 100 |
0 |
|
50 to 70 |
5 |
|
< 50 |
7 |
ICU stay before transplant |
no |
0 |
|
yes |
7 |
ECMO before transplant |
no |
0 |
|
yes |
6 |
days on waiting list |
<= 60 days |
0 |
|
> 60 days |
4 |
number of lungs |
single |
0 |
|
double |
4 |
total score =
= SUM(points for all 10 parameters)
Interpretation:
• minimum score: 0
• maximum score: 57
• The higher the score the greater the risk for acute renal failure.
Score |
Risk Group |
Predicted Rate ARF |
0 to 15 |
low |
< 5% |
16 to 24 |
moderate |
5 to 13% |
25 to 57 |
high |
> 13% |
Specialty: Nephrology, Clinical Laboratory, Surgery, general